VMS and Menopause: KNDy Neurons, NK Receptors, and Practical Insights - Episode 6

VMS Treatment Guidelines

,

Panelists discuss key considerations for women taking hormonal therapy, emphasizing the importance of individualized treatment plans and shared decision-making to evaluate the risk-benefit profile of therapy.

EP. 1: Overview of KNDy neurons
EP. 2: VMS Symptoms and Neurokinin Receptor Antagonists
EP. 3: Neurokinin and Estrogen Balance in Menopausal Hot Flashes for Primary Care
EP. 4: Fezolinetant Guidelines and Emerging Data on Menopause and Liver Health
EP. 5: Molecular Comparison and Safety Profiles of Fezolinetant and Elinzanetant
Now Viewing
EP. 6: VMS Treatment Guidelines
EP. 7: Malignancy Risks of Neurokinin Receptor Antagonists
EP. 8: Nonestrogen Treatments for Menopause
EP. 9: Guidance for PCPs: Streamlining Menopause Care

Individualized therapy with shared decision-making is essential when evaluating the risk-benefit profile of hormonal therapy. What are some key considerations for a woman taking hormonal therapy?